menu
    • menu

    Company profile for Intellipharmaceutics Corporation

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are engaged in the research, development, and commercialization of controlled-release and targeted pharmaceutical products. Controlled-release means releasing a drug into the bloodstream or at a target site in the body, over an extended period of time or at predetermined times. In some circumstances, controlled-release drug delivery can enhance efficacy and patient compliance as compared to immediate release formats for the...
    We are engaged in the research, development, and commercialization of controlled-release and targeted pharmaceutical products. Controlled-release means releasing a drug into the bloodstream or at a target site in the body, over an extended period of time or at predetermined times. In some circumstances, controlled-release drug delivery can enhance efficacy and patient compliance as compared to immediate release formats for the same drug

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Intellipharmaceutics CorporationCanada Flag
    Country
    Country
    Canada
    Address
    Address
    Intellipharmaceutics International, Inc.30 Worcester RoadToronto, OntarioCanad...
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://intellipharmaceutics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Intellipharmaceutics Announces Downgrade To OTC Expert Market
    Intellipharmaceutics Announces Downgrade To OTC Expert Market

    14 Jun 2024

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=877212&lang=en

    ACCESSWIRE
    14 Jun 2024
    Share Share
    Intellipharmaceutics Announces Transfer of Listing to NEX and Stock Option Plan
    Intellipharmaceutics Announces Transfer of Listing to NEX and Stock Option Plan

    13 Mar 2024

    // ACCESSWIRE

    https://www.accesswire.com/842792/intellipharmaceutics-international-inc-announces-transfer-of-listing-to-nex-and-new-stock-option-plan

    ACCESSWIRE
    13 Mar 2024
    Share Share
    Intellipharmaceutics Announces Cease Trade Order
    Intellipharmaceutics Announces Cease Trade Order

    06 Mar 2024

    // ACCESSWIRE

    https://www.accesswire.com/840033/intellipharmaceutics-announces-cease-trade-order

    ACCESSWIRE
    06 Mar 2024
    Share Share
    Intellipharmaceutics Announces Delay in Filing Audited Financial Statements
    Intellipharmaceutics Announces Delay in Filing Audited Financial Statements

    26 Feb 2024

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=836829&lang=en

    ACCESSWIRE
    26 Feb 2024
    Share Share
    Intellipharmaceutics International Inc. Announces Stock Option Grant
    Intellipharmaceutics International Inc. Announces Stock Option Grant

    08 Feb 2024

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=832396&lang=en

    ACCESSWIRE
    08 Feb 2024
    Share Share
    Intellipharmaceutics Receives Conditional Approval to List on TSX Exchange
    Intellipharmaceutics Receives Conditional Approval to List on TSX Exchange

    02 Jan 2024

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=821407&lang=en

    ACCESSWIRE
    02 Jan 2024
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search